Dudediligence.

QuidelOrtho Corporation

QDELNASDAQ · In Vitro & in Vivo Diagnostic Substances
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$111,965

1 notice · 4,026 sh

Oct 2025 to Oct 2026

Reported ·

$111,963

1 sale · 8 buys · $1,247,754 bought

Oct 2025 to Jun 2026

The two figures cover different periods.

The one reported sale does not carry the 10b5-1 box. It is under 0.01% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2025-11-25: KENNETH WIDDER, Form 1442025-11-19: Blaser Brian J., bought2025-11-21: POLAN MARY LAKE PH D, bought2025-11-24: Busky Joseph M., bought2025-11-25: WIDDER KENNETH J, sold2025-11-26: Wilkins Joseph D Jr., bought2025-12-10: RHOADS ANN D, bought2026-02-13: Strobeck Matthew, bought2026-02-13: Busky Joseph M., bought2026-02-13: Blaser Brian J., bought
under a no plan named▼ sale▲ buysize is dollars

Form 144 notices, newest first

2025-11-25KENNETH WIDDER, Director$111,965
4,026 shno plan date144 ↗
Form 4, 2025-11-25: sold 4,026 at $27.81 Form 4 ↗